Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Summers

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
British Journal of Haematology|June 10, 2000
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular responseJ M Foran, R K Gupta, D Cunningham, et al.
Cell|December 14, 2011
The STARD9/Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assemblyJorge Z Torres, Matthew K Summers, David Peterson, et al.
Cancer Research|February 15, 2020
LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane ResistanceMelyssa S Roberts, Jennifer M Sahni, Morgan S Schrock, et al.
Cancer Research|August 16, 2017
Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET InhibitorsJennifer M Sahni, Sylvia S Gayle, Bryan M Webb, et al.
Veterinary and Comparative Oncology|May 31, 2023
Establishment and characterization of two novel patient-derived lines from canine high-grade gliomaMorgan S Schrock, Abigail A Zalenski, Miranda M Tallman, et al.
Cell Host & Microbe|May 24, 2016
Intracellular Action of a Secreted Peptide Required for Fungal VirulenceChristina M Homer, Diana K Summers, Alexi I Goranov, et al.
Experimental Hematology & Oncology|July 13, 2022
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cellsWalter Hanel, Pushpa Lata, Youssef Youssef, et al.
Scientific Reports|August 1, 2023
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathwaysKarnika Singh, Chunhua Han, Jessica L Fleming, et al.
Journal of Hematology & Oncology|January 16, 2021
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Bonnie Harrington, et al.
Leukemia|July 10, 2009
Array-based DNA methylation profiling in follicular lymphomaC O'Riain, D M O'Shea, Y Yang, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
British Journal of Haematology|June 10, 2000
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular responseJ M Foran, R K Gupta, D Cunningham, et al.
Cell|December 14, 2011
The STARD9/Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assemblyJorge Z Torres, Matthew K Summers, David Peterson, et al.
Cancer Research|February 15, 2020
LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane ResistanceMelyssa S Roberts, Jennifer M Sahni, Morgan S Schrock, et al.
Cancer Research|August 16, 2017
Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET InhibitorsJennifer M Sahni, Sylvia S Gayle, Bryan M Webb, et al.
Veterinary and Comparative Oncology|May 31, 2023
Establishment and characterization of two novel patient-derived lines from canine high-grade gliomaMorgan S Schrock, Abigail A Zalenski, Miranda M Tallman, et al.
Cell Host & Microbe|May 24, 2016
Intracellular Action of a Secreted Peptide Required for Fungal VirulenceChristina M Homer, Diana K Summers, Alexi I Goranov, et al.
Experimental Hematology & Oncology|July 13, 2022
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cellsWalter Hanel, Pushpa Lata, Youssef Youssef, et al.
Scientific Reports|August 1, 2023
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathwaysKarnika Singh, Chunhua Han, Jessica L Fleming, et al.
Journal of Hematology & Oncology|January 16, 2021
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Bonnie Harrington, et al.
Leukemia|July 10, 2009
Array-based DNA methylation profiling in follicular lymphomaC O'Riain, D M O'Shea, Y Yang, et al.
Pageof 22